Inmed Pharmaceuticals Inc. · NASDAQ:INM
Schneeberger Daniel bought 468,551 Inmed Pharmaceuticals Inc. shares (Form 4)
Traded May 19, 2026 · Filed May 21, 2026
On May 19, 2026, Schneeberger Daniel (10% owner) bought 468,551 Inmed Pharmaceuticals Inc. shares at an average US$1.54 for US$722K, leaving 800,000 shares. Filed May 21, 2026 (Form 4).
- Bought
- 468,551 shares
- Price
- US$1.54 average (US$1.50 to US$1.60)
- Value
- US$722K
- Holding after
- 800,000 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 19, 2026 | Common Shares | Buy | 68,551 | US$1.60 | 400,000 | Indirect |
| May 19, 2026 | Common Shares | Buy | 200,000 | US$1.56 | 600,000 | Indirect |
| May 19, 2026 | Common Shares | Buy | 200,000 | US$1.50 | 800,000 | Indirect |
Source
Related
- Inmed Pharmaceuticals Inc.
- Schneeberger Daniel
- Inmed Pharmaceuticals Inc. shareholders
- Form 4 · Schneeberger Daniel · Sep 16, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 15, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 8, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Oct 7, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 5, 2026
- Schedule 13G · Ikarian Capital, LLC · Aug 14, 2026